These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 23246391

  • 1. Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention.
    Hlatky MA, Solomon MD, Shilane D, Leong TK, Brindis R, Go AS.
    J Am Coll Cardiol; 2013 Jan 22; 61(3):295-301. PubMed ID: 23246391
    [Abstract] [Full Text] [Related]

  • 2. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ, Kibiro M, Eichhöfer J, Curzen NP.
    Postgrad Med J; 2005 Jun 22; 81(956):401-3. PubMed ID: 15937208
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
    Kocas C, Abaci O, Oktay V, Coskun U, Bostan C, Yildiz A, Arat Ozkan A, Gurmen T, Ersanli M.
    J Clin Pharm Ther; 2013 Dec 22; 38(6):476-9. PubMed ID: 23992279
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.
    Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS.
    QJM; 2009 Dec 01; 102(12):843-9. PubMed ID: 19828644
    [Abstract] [Full Text] [Related]

  • 9. Full prescription coverage versus usual prescription coverage after coronary artery bypass graft surgery: analysis from the post-myocardial infarction free Rx event and economic evaluation (FREEE) randomized trial.
    Kulik A, Desai NR, Shrank WH, Antman EM, Glynn RJ, Levin R, Reisman L, Brennan T, Choudhry NK.
    Circulation; 2013 Sep 10; 128(11 Suppl 1):S219-25. PubMed ID: 24030410
    [Abstract] [Full Text] [Related]

  • 10. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.
    N Z Med J; 2011 Sep 23; 124(1343):18-27. PubMed ID: 21964009
    [Abstract] [Full Text] [Related]

  • 11. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H, Ichimiya S, Kanashiro M, Aoyama T, Ogawa Y, Murakami R, Amano T, Naruse K, Matsubara T, Murohara T.
    Clin Ther; 2006 Nov 23; 28(11):1812-9. PubMed ID: 17213001
    [Abstract] [Full Text] [Related]

  • 12. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
    Ivers NM, Schwalm JD, Jackevicius CA, Guo H, Tu JV, Natarajan M.
    Can J Cardiol; 2013 Nov 23; 29(11):1408-14. PubMed ID: 23816280
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
    Barry AR, Koshman SL, Norris CM, Ross DB, Pearson GJ.
    Pharmacotherapy; 2014 May 23; 34(5):464-72. PubMed ID: 24877186
    [Abstract] [Full Text] [Related]

  • 14. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr 23; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 15. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM, Yazbek N, Lakkis NM.
    Catheter Cardiovasc Interv; 2004 Jun 23; 62(2):193-7. PubMed ID: 15170709
    [Abstract] [Full Text] [Related]

  • 16. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P, Etemad L.
    J Invasive Cardiol; 2005 Jun 23; 17(6):307-11. PubMed ID: 16003005
    [Abstract] [Full Text] [Related]

  • 17. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP, Perez de la Hoz R, Brito VM, Duronto E, Dabbous OH, Gore JM, Anderson FA, GRACE Investigators.
    Int J Cardiol; 2007 Jun 25; 119(1):65-72. PubMed ID: 17045681
    [Abstract] [Full Text] [Related]

  • 18. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ, Quinton HB, Piper W, Hernandez F, Morton J, Hettleman B, Hearne M, Nugent W, O'Connor GT, Malenka DJ, Northern New England Cardiovascular Disease Study Group.
    Ann Thorac Surg; 2004 Aug 25; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [Abstract] [Full Text] [Related]

  • 19. Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia.
    Livori AC, Ademi Z, Ilomäki J, Nelson AJ, Bell JS, Morton JI.
    Heart Lung Circ; 2024 Oct 25; 33(10):1439-1449. PubMed ID: 38964944
    [Abstract] [Full Text] [Related]

  • 20. Comparison of results of coronary artery bypass grafting versus percutaneous coronary intervention in octogenarians.
    Gunn J, Kuttila K, Vasques F, Virtanen R, Lahti A, Airaksinen J, Biancari F.
    Am J Cardiol; 2012 Oct 15; 110(8):1125-9. PubMed ID: 22762714
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.